Clinical Trial Update: Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs Aflibercept in Patients With DME [Phase 2]

View source ↗

Summary

Phase 2 trial comparing inflammation and pain after injection of ranibizumab versus aflibercept in diabetic macular edema has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Aflibercept (Aflibercept)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: Arshad Khanani | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2019-04-26